[Image source=Reuters Yonhap News]

[Image source=Reuters Yonhap News]

View original image

[Asia Economy New York=Correspondent Baek Jong-min] The U.S. Food and Drug Administration (FDA) judged on the 15th (local time) that the novel coronavirus disease (COVID-19) vaccine developed by pharmaceutical company Moderna is effective in preventing infection, according to the Associated Press.


In this regard, The New York Times, citing sources, reported that the FDA will approve the emergency use of the Moderna vaccine.


The FDA advisory committee, the Vaccines and Related Biological Products Advisory Committee (VRBPAC), is scheduled to hold a meeting on the 17th to recommend emergency use of the Moderna vaccine. After this meeting, emergency use approval for the Moderna vaccine is expected on the 18th.



If the Moderna vaccine receives emergency use approval from the FDA, it will become the second vaccine available for use in the United States following the Pfizer-BioNTech vaccine.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing